Search filters

List of works by Geraldine O'Sullivan Coyne

A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas.

scientific article published on 31 May 2018

A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

scientific article published on 04 September 2019

Adding fuel to the fire: immunogenic intensification

scientific article published in January 2014

Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)

scientific article published on 10 September 2019

Class act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma.

scientific article

Clinical experience with ramucirumab : outcomes in breast cancer

scientific article published on 12 July 2014

Curcumin induces apoptosis-independent death in oesophageal cancer cells.

scientific article published on 6 October 2009

Effectiveness and safety of eribulin mesylate: a new therapeutic option in the treatment of metastatic breast cancer.

scientific article

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

scientific article published on 21 October 2019

Hidradenitis suppurativa-like lesions associated with pharmacologic inhibition of gamma-secretase.

scientific article published on 11 November 2017

Immune play: defending the liver

scientific article published on 12 January 2015

Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOM

article published in 2014

MABp1 for the treatment of colorectal cancer.

scientific article published on 10 July 2017

Nivolumab: promising survival signal coupled with limited toxicity raises expectations

scientific article published on 3 March 2014

PARP Inhibitors in Reproductive System Cancers: Current Use and Developments

scientific article published on 11 January 2017

Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors

scientific article published on 23 October 2020